Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Immunogenicity”

5,455 trials

Showing 20 of 5,455 results

Testing effectiveness (Phase 2)Study completedNCT00978120
What this trial is testing

Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma

Who this might be right for
H1N1 Influenza Virus
National Institute of Allergy and Infectious Diseases (NIAID) 390
Large-scale testing (Phase 3)Study completedNCT01086423
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

Who this might be right for
TetanusPoliomyelitisAcellular Pertussis+2 more
GlaxoSmithKline 985
Early research (Phase 1)Study completedNCT00027261
What this trial is testing

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 110
Very early researchUnknownNCT05679466
What this trial is testing

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Who this might be right for
Prevention of COVID-19 Caused by SARS-CoV-2
Yu Qin 3,300
Large-scale testing (Phase 3)Study completedNCT03390166
What this trial is testing

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Who this might be right for
Influenza
Mahidol University 945
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05380388
What this trial is testing

A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )

Who this might be right for
Plasmodium Vivax InfectionMalaria Vaccine
University of Oxford 36
Post-approval studies (Phase 4)Study completedNCT01817270
What this trial is testing

Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine

Who this might be right for
Chickenpox
Changchun Keygen Biological Products Co., Ltd. 368
Early research (Phase 1)Study completedNCT00111605
What this trial is testing

Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 144
Early research (Phase 1)Study completedNCT00072605
What this trial is testing

Experimental Ebola Vaccine Trial

Who this might be right for
Hemorrhagic Fever, EbolaHealthy
National Institute of Allergy and Infectious Diseases (NIAID) 27
Early research (Phase 1)Study completedNCT02627456
What this trial is testing

Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 409
Testing effectiveness (Phase 2)Study completedNCT05324137
What this trial is testing

CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Who this might be right for
Chronic Rhinosinusitis With Nasal Polyps
Keymed Biosciences Co.Ltd 88
Post-approval studies (Phase 4)UnknownNCT05389137
What this trial is testing

To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years

Who this might be right for
Influenza
Wuhan Institute of Biological Products Co., Ltd 360
Testing effectiveness (Phase 2)Study completedNCT00440362
What this trial is testing

A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza

Who this might be right for
Influenza
AlphaVax, Inc. 216
Testing effectiveness (Phase 2)UnknownNCT03806686
What this trial is testing

Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare Workers

Who this might be right for
Tuberculosis
Quratis Inc. 107
Early research (Phase 1)Study completedNCT01707069
What this trial is testing

A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid

Who this might be right for
Allergic Rhinoconjunctivitis
Immunomic Therapeutics, Inc. 24
Early research (Phase 1)Study completedNCT00657683
What this trial is testing

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age

Who this might be right for
Invasive Group B Streptococcus (GBS) Disease
Novartis Vaccines 65
Early research (Phase 1)Study completedNCT03282851
What this trial is testing

Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456

Who this might be right for
Healthy
Fresenius Kabi SwissBioSim GmbH 696
Early research (Phase 1)Study completedNCT01986010
What this trial is testing

Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)

Who this might be right for
Cytomegalovirus Infections
Merck Sharp & Dohme LLC 190
Post-approval studies (Phase 4)Study completedNCT01031303
What this trial is testing

Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 123
Testing effectiveness (Phase 2)Study completedNCT04993586
What this trial is testing

Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)

Who this might be right for
COVID-19 Lower Respiratory Infection
AnGes, Inc. 422
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation